| Quinolone resistance from a transferable plasmid L Martínez-Martínez, A Pascual, GA Jacoby The Lancet 351 (9105), 797-799, 1998 | 1652 | 1998 |
| Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients J Rodríguez-Bano, MD Navarro, L Romero, L Martínez-Martínez, ... Journal of clinical microbiology 42 (3), 1089-1094, 2004 | 705 | 2004 |
| Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues V Miriagou, G Cornaglia, M Edelstein, I Galani, CG Giske, M Gniadkowski, ... Clinical microbiology and infection 16 (2), 112-122, 2010 | 558 | 2010 |
| Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence E Padilla, E Llobet, A Doménech-Sánchez, L Martínez-Martínez, ... Antimicrobial agents and chemotherapy 54 (1), 177-183, 2010 | 507 | 2010 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 479 | 2017 |
| Emergence of Plasmid-Mediated Quinolone Resistance in Escherichia coli in Europe H Mammeri, M Van De Loo, L Poirel, L Martinez-Martinez, P Nordmann Antimicrobial agents and chemotherapy 49 (1), 71-76, 2005 | 459 | 2005 |
| Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of … F Fernández-Cuenca, L Martínez-Martínez, MC Conejo, JA Ayala, ... Journal of Antimicrobial Chemotherapy 51 (3), 565-574, 2003 | 433 | 2003 |
| Plasmid-mediated quinolone resistance: an update JM Rodríguez-Martínez, ME Cano, C Velasco, L Martínez-Martínez, ... Journal of Infection and Chemotherapy 17, 149-182, 2011 | 402 | 2011 |
| Roles of β-Lactamases and Porins in Activities of Carbapenems and Cephalosporins against Klebsiella pneumoniae L Martínez-Martínez, A Pascual, S Hernández-Allés, D Alvarez-Díaz, ... Antimicrobial agents and chemotherapy 43 (7), 1669-1673, 1999 | 362 | 1999 |
| In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins L Martinez-Martinez, S Hernández-Allés, S Albertí, JM Tomás, VJ Benedi, ... Antimicrobial Agents and Chemotherapy 40 (2), 342-348, 1996 | 346 | 1996 |
| Biofilm formation in Acinetobacter baumannii: associated features and clinical implications J Rodríguez‐Baño, S Marti, S Soto, F Fernández‐Cuenca, JM Cisneros, ... Clinical microbiology and infection 14 (3), 276-278, 2008 | 336 | 2008 |
| Redefining extended-spectrum β-lactamases: balancing science and clinical need CG Giske, AS Sundsfjord, G Kahlmeter, N Woodford, P Nordmann, ... Journal of Antimicrobial Chemotherapy 63 (1), 1-4, 2009 | 315* | 2009 |
| Mecanismos de acción de los antimicrobianos J Calvo, L Martínez-Martínez Enfermedades infecciosas y microbiología clínica 27 (1), 44-52, 2009 | 306 | 2009 |
| Nationwide Study of Escherichia coli and Klebsiella pneumoniae Producing Extended-Spectrum β-Lactamases in Spain JR Hernández, L Martínez-Martínez, R Cantón, TM Coque, A Pascual Antimicrobial agents and chemotherapy 49 (5), 2122-2125, 2005 | 261 | 2005 |
| Porin expression in clinical isolates of Klebsiella pneumoniae S Hernández-Allés, S Albertí, D Álvarez, A Doménech-Sánchez, ... Microbiology 145 (3), 673-679, 1999 | 253 | 1999 |
| Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones G Cabot, AA Ocampo-Sosa, MA Domínguez, JF Gago, C Juan, F Tubau, ... Antimicrobial agents and chemotherapy 56 (12), 6349-6357, 2012 | 246 | 2012 |
| Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia G Peralta, MB Sanchez, JC Garrido, I De Benito, ME Cano, ... Journal of antimicrobial chemotherapy 60 (4), 855-863, 2007 | 241 | 2007 |
| Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study G Cabot, AA Ocampo-Sosa, F Tubau, MD Macia, C Rodríguez, B Moya, ... Antimicrobial agents and chemotherapy 55 (5), 1906-1911, 2011 | 240 | 2011 |
| Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii C Rumbo, E Gato, M López, C Ruiz de Alegría, F Fernández-Cuenca, ... Antimicrobial agents and chemotherapy 57 (11), 5247-5257, 2013 | 239 | 2013 |
| Extended‐spectrum β‐lactamases and the permeability barrier L Martínez‐Martínez Clinical Microbiology and Infection 14, 82-89, 2008 | 236 | 2008 |
